BLUEJET vs SANOFICONR: Stock Comparison

Blue Jet Healthcare Limited vs Sanofi Consumer Healthcare India Limited

Live data: 22 July 2026, 2:57 PM IST • Source: NSE and company filings

Sanofi Consumer Healthcare India Limited is the larger company by market capitalisation. Sanofi Consumer Healthcare India Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Blue Jet Healthcare Limited and Sanofi Consumer Healthcare India Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLUEJET is more favourable on 2 of 11 scored metrics and SANOFICONR on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SANOFICONR is the larger company
₹10,603 Cr vs ₹10,169 Cr
P/E Ratio
SANOFICONR has a lower P/E
41.08x vs 41.21x
P/B Ratio
BLUEJET has a lower P/B
7.51x vs 27.59x
EPS
SANOFICONR has higher earnings per share
₹112.12 vs ₹14.27
Dividend Yield
SANOFICONR has a higher dividend yield
2.88% vs 0.2%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs -31.1%
EPS Growth (TTM YoY)
SANOFICONR has faster EPS growth
35.7% vs -41.5%
ROE
SANOFICONR has a higher ROE
71.6% vs 52.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLUEJETSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLUEJETSANOFICONR
Live Price₹584.8₹4,622.1
Day Change-0.8%0.99%
Volume5.49 L3,965
52-Week High₹1,022₹5,512
52-Week Low₹325₹3,975
Distance from 52W High-42.78%-16.14%

Valuation

MetricBLUEJETSANOFICONR
Market Cap₹10,169 Cr₹10,603 Cr
P/E Ratio41.21x41.08x
P/B Ratio7.51x27.59x
EPS₹14.27₹112.12
Book Value₹78.41₹166.71
Dividend Yield0.2%2.88%

Growth

MetricBLUEJETSANOFICONR
Revenue Growth (TTM YoY)-31.1%32.8%
EPS Growth (TTM YoY)-41.5%35.7%
Qtr Sales Growth32.8%
Qtr Profit Growth35.6%

Profitability & Leverage

MetricBLUEJETSANOFICONR
ROE52.1%71.6%
ROCE57.3%89.9%
Net Margin27.25%27.58%
Operating Margin41.3%35.7%
Debt to Equity0.16x0.06x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLUEJETSANOFICONR
Promoter Holding79.81%71.27%
FII Holding0.4% 0.48 pp2.76% 0.07 pp
DII Holding4.65% 0.14 pp17.57% 0.24 pp
Public Holding15.14% 0.34 pp8.4% 0.16 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Blue Jet Healthcare Limited and Sanofi Consumer Healthcare India Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.